Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Walgreens Acquires Pharmacy Company Shields Health Solutions
Walgreens Boots Alliance, Inc. (WBA), the holding company that owns the retail pharmacy chain Walgreens, has announced a new majority investment for Shields Health Solutions valued at $970 million. Shields Health Solutions is a specialty pharmacy that partners with hospitals and health systems to provide integrated care management for special disease states. Over the last two years, Shields has rapidly expanded its platform, representing more than one million specialty patients across more than 30 disease states, with more than 70 health system partners nationwide.WBA will acquire approximately 71% ownership of Shields, with an option to acquire the remaining equity interests in the... Read More »
PE-Backed Broadstep Behavioral Health Expands in North Carolina
Broadstep Behavioral Health, a portfolio company of Bain Capital Double Impact Fund, has announced its fourth acquisition of 2021. The behavioral health network is adding Coastal Southeastern United Care, a not-for-profit that offers a continuum of community-based behavioral health and substance abuse services for adults, adolescents, and children with significant identified symptoms interfering with their functioning role in family, school, employment or community. The agency is located in Shallotte, North Carolina and currently serves ten counties in that state: Bladen, Brunswick, Cleveland, Columbus, Gaston, Lincoln, New Hanover, Pender, Robeson,... Read More »
WELL Health Technologies Corp. Strikes Another Deal
WELL Health Technologies Corp., the Canadian digital health company, has announced a new deal for Aware MD based in Ontario. The deal is valued at CAD 4.5 million, or roughly $3.6 million. The deal also includes a conditional earn-out based on the overall operating performance of Aware MD of up to $2.7 million. In 2020, Aware MD generated $1.58 million in revenue. Aware MD is an enterprise-class electronic medical records (EMR) provider with an array of products and services for disease specialties including cardiology, radiology, endocrinology, and rheumatology. Aware MD developed the Cerebrum proprietary workflow solution designed for specialists to manage busy and multi-diagnostic... Read More »
Senior Helpers Acquires Miller Home Care
The national home health chain Senior Helpers has announced the acquisition of Miller Home Care, LLC, a home health agency based in Milwaukee. Miller Home Care provides in-home senior care, offering services ranging from companion care for seniors who need daily assistance to in-depth specialized care for those with Alzheimer’s, Dementia, Parkinson’s and other chronic diseases. No terms were disclosed. This is the first deal for Senior Helpers since it became a subsidiary of Advocate Aurora Enterprises, which is, in turn, a subsidiary of Advocate Aurora Health, one of the 12 largest not-for-profit, integrated health systems in the nation. Advocate Aurora Enterprise was formed to help the... Read More »
JLL Facilitates Recapitalization of 31-Building MOB Portfolio
JLL Capital Markets represented Montecito Medical Real Estate in the $245 million recapitalization and financing of a 31-property medical office building portfolio with AEW Capital Management. The institutionally managed portfolio consists of 27 single-tenant and four multi-tenant buildings totaling 545,813 square feet across 10 states. The properties are purposely aligned with major health systems and dominant physician groups. Additionally, JLL worked on behalf of the new ownership group to secure $176 million in acquisition financing through BMO Harris. BMO’s dedicated team of real estate experts stay up to date with current market trends and conditions to help developers, REITs,... Read More »
Industry Experts Talk Healthcare M&A Market at iiBig Virtual Roundtable
The editorial team at Irving Levin Associates attended the keynote panel at the iiBig 13th Annual Investment and M&A Opportunities in Healthcare Virtual Conference aptly titled “State of the Healthcare M&A Industry.” It was led by Nick Donkar, Head Deals Leader – Healthcare, PricewaterhouseCoopers, and featured John W. Jones, Jr., Partner, Troutman Pepper LLP, Burk Lindsey, Managing Director, Raymond James, Michael Ory, Managing Director, Brentwood Capital Advisors and Neil Pickett, VP and Deputy Chief of Staff Indiana University Health. The panel managed to paint an in-depth portrait of the healthcare M&A market and the forces driving such high growth this... Read More »KSL Biomedical Expands into Canada with Pulse Scientific Acquisition
KSL Biomedical Inc. has entered the Canadian market with the acquisition of Burlington, Ontario-based Pulse Scientific Inc., extending its international base for product distribution and laboratory sales, while positioning KSL for future acquisitions in the Burlington/Toronto area and beyond. Pulse Scientific is a privately-owned incorporation founded in 1992 that specializes in the supply of laboratory diagnostic tests for medical labs across Canada. Some examples of these tests include Syphillis, Rheumatoid Arthritis, drugs of abuse and microbiological products. KSL Biomedical is a translational medicine technology company based in Williamsville, New York. KSL has been growing rapidly... Read More »
AzurRz BioPharma Acquires First Wave Bio
AzurRz BioPharma, Inc., a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that it has entered into a definitive agreement to acquire First Wave Bio, Inc. in a stock and cash transaction valued at $229 million. H.C. Wainwright & Co. acted as advisor to AzurRx in connection with the acquisition. Founded in 2015, First Wave Bio, Inc. is a clinical-stage biotechnology company specializing in the development of novel, gut-targeted, small molecule therapies for the treatment of auto-immune inflammatory bowel diseases (IBD) and other serious conditions. AzurRx also announced that it... Read More »
